If you could vote on Brexit now which option would you choose?

Gilead's remdesivir reduces COVID-19 mortality risk- data

Gilead Sciences Inc (GILD.O) said an analysis showed its antiviral remdesivir reduced mortality rates in hospitalized patients with COVID-19 and increased the likelihood of being discharged by day 28 after a five-day course of the treatment. The drugmaker said on Monday it analyzed data from 98,654 patients from three retrospective studies of the real-world treatment of hospitalized COVID-19 patients.

Reuters - June 21, 2021

View the full story here: https://www.reuters.com/business/healthcare-pharmaceuticals/gileads-remdesivir-reduces-covid-19-mortality-risk-data-2021-06-21/